New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerati... (nearly 700000 people in the U.S. is mark...)

HOME >> BIOLOGY >> TECHNOLOGY

New Phase 3 Study Results Show REMICADE® is Effective in the Treatment of Pediatric Patients With Moderate to Severe Ulcerative Colitis

Date:5/9/2011

nearly 700,000 people in the U.S., is marked by the inflammation and ulceration of the colonic mucosa, or innermost lining, which may lead to bloody stools, severe diarrhea and frequent abdominal pain. Tiny open sores, or ulcers, form on the surface of the lining where they bleed and produce pus and mucus. Symptoms of the disease may lead to loss of appetite, subsequent weight loss, and fatigue. UC is a chronic disease, and there is no cure. Although progress has been made in IBD research, investigators do not know what causes this disease.

About REMICADE

REMICADE was the first anti-tumor necrosis factor (TNF)-alpha treatment to be approved in three different therapeutic areas: gastroenterology, rheumatology and dermatology. REMICADE has demonstrated broad clinical utility with indications in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy of REMICADE have been well established in clinical trials over the past 17 years and through commercial experience with more than 1.3 million patients treated worldwide.

In the U.S., REMICADE is approved for the following indications:

Reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately to severely active RA, when administered in combination with methotrexate.
Reducing signs and symptoms in patients with active AS.
Reducing signs and symptoms and inducing and maintaining clinical remission in adult and pediatric patients with moderately to severely active CD who have had an inadequate response to conventional therapy.
Reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients wi
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
2. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
3. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
4. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
5. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
6. PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet
7. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
8. Michigan Innovation Equipment Depot Launches Next Phase of Distribution
9. Phase 1b/2a Program Commences for RVX-208
10. Chiltern Early Phase: Fully Integrated and Business Ready
11. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours

Post Your Comments:

(Date:6/19/2013)... , June 19, 2013 MO BIO ... and other challenging microbial nucleic acid purification, announces ... Kit, for extraction of pure protein from all ... coincides with the 20 th anniversary of ... capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) ...

(Date:6/19/2013)... 2013 Biotechnology industry pioneer Amgen (NASDAQ: ... provider BlackLine Systems and enterprise application software leader ... a webinar next week entitled "No Account Left Behind! ... SAP to Help Keep Its Account Reconciliations in Good Shape ... The webinar, geared at finance, accounting, audit and ...

(Date:6/19/2013)... A new look at “big glass” and ... will highlight technical sessions at SPIE Photomask Technology ... 33rd year, the three-day event is the industry’s largest ... approximately 100 technical presentations and numerous networking lunches and ... optics and photonics , the meeting will be held ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...

[0] MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil [0] Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations [0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013

... Biotechnologies Can Help Children With Diabetes Get Back... -- BEIJING, Aug. 24 /PRNewswire-Asia/ -- ... ... --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...

... Zeus, Inc., a global leader in material science and ... catalog in 6 languages: English, Chinese, French, German, Japanese, ... bilingual Technical Account Managers and modified customer support hours ... are available for download at http://www.zeusinc.com . ...

... Aug. 20 Scott & White Healthcare Board of ... of Scott & White Healthcare President and CEO Alfred ... the first President and CEO for the merged hospital ... Healthcare, will assume the role of President of the ...

Cached Biology Technology:Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 2 Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 3 Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 4 Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 5 Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives 6 Zeus Catalog Available in Six Languages 2 Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation 2 Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation 3 Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation 4

Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives Zeus Catalog Available in Six Languages Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation

(Date:6/19/2013)... University study offers further proof that the divergence of ... years ago was profoundly influenced by mutations to DNA ... off. , The study, published June 9 in ... that regulation of genes must play an important role ... and chimps in the proteins produced by genes. Indeed, ...

(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...

(Date:6/18/2013)... Torrent, Ph.D., Medical Research Council, Laboratory of Molecular ... a 2013 ICAAC Young Investigator Award. Torrent is ... developing the first algorithm to predict antimicrobial regions ... said, "we are now applying this algorithm to ... antimicrobial peptide leads with very appealing results." ...

Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2 New research backs theory that genetic 'switches' play big role in human evolution 3 Immunity mechanism discovered 2 The American Society for Microbiology honors Marc Torrent 2

[0] New research backs theory that genetic 'switches' play big role in human evolution [0] Immunity mechanism discovered [0] The American Society for Microbiology honors Marc Torrent

... study of college students at The Pennsylvania State ... develop higher-level skills by participating in cooperative (team) ... Elsa Snchez and Richard Craig, professors in the ... from 2003-2005 in their Plant Systematics course. The ...

... love it fresh, canned and frozen. It,s grown in every ... American Society of Horticultural Science, adds up to a whopping ... words, sweet corn is big business. Fresh market production ... only ten percent of the annual volume marketed during winter ...

... in legumes and bran could protect DNA from ... University of Maryland report. Inositol and inositol hexaphosphate ... skin cancer-prone mouse from exposure to ultraviolet B ... the team reported today at the American Association ...

Cached Biology News:Teamwork improves learning and career success 2 How sweet is it? 2 Antioxidants could provide all-purpose radiation protection 2 Antioxidants could provide all-purpose radiation protection 3

Teamwork improves learning and career success How sweet is it?Antioxidants could provide all-purpose radiation protection

...

... A sleek design loaded with class-leading features, the 1400 ... your work is safe and consistent every time you ... new 1400 Series reduces power consumption by as much ... dollars over the life of the cabinet. Multiply ...

... Sensitive Bio (for heat-labile and very volatile ... to specific applications of molecular biology and ... heat-labile samples. The RC systems can be ... and a wide selection of rotors (eliminating ...

... purification systems provide high speed purification of ... offer increased throughput and reproducible results. The ... mL and KingFisher 96, covering sample volumes ... consists of an instrument, specially designed plastics ...

Biology Products:

Kit for BASE20/50 units from Wave Biotech now part of GE Healthcare Forma 1400 from Thermo Scientific RC Sensitive Bio from Thermo Scientific KingFisher mL magnetic particle processor (100-240 V) from Thermo Scientific